Medicare Enrolled
Dr. Jennifer Byer, MD
Hematology · Vero Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Byer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Byer? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Byer
Dr. Jennifer Byer is a hematology in Vero Beach, FL, with 15 years in practice. Based on federal Medicare data, Dr. Byer performed 247,310 Medicare services across 9,128 unique beneficiaries.
Between the years covered by Open Payments, Dr. Byer received a total of $20,223 from 84 pharmaceutical and/or device companies across 1146 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Byer is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice▲ Top 13% volume in FL$ $20,223 industry payments
Medicare Practice Summary
Medicare Utilization ↗247,310
Medicare services
Top 13% in FL for hematology
9,128
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~16,487 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 75,480 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 34,800 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 18,720 | $1 | $5 |
| Paclitaxel chemotherapy injection | 15,404 | $0 | $2 |
| Daratumumab injection (Darzalex) | 15,300 | $38 | $110 |
| Oxaliplatin chemotherapy injection | 9,860 | $0 | $12 |
| Epoetin alfa injection (Procrit) for anemia | 8,177 | $6 | $23 |
| Nivolumab injection (Opdivo) | 7,120 | $24 | $72 |
| Denosumab injection (Prolia/Xgeva) | 6,360 | $18 | $51 |
| Injection, eflapegrastim-xnst, 0.1 mg | 5,016 | $25 | $116 |
| Immune globulin infusion (Gammagard) | 4,184 | $36 | $108 |
| Iron sucrose injection (Venofer) | 3,900 | $0 | $5 |
| Complete blood count (CBC) with differential | 3,541 | $8 | $29 |
| Dexamethasone injection (steroid) | 3,416 | $0 | $3 |
| Blood draw (venipuncture) | 3,141 | $8 | $9 |
| Injection, durvalumab, 10 mg | 3,023 | $62 | $191 |
| Epoetin alfa injection (Retacrit) for anemia | 2,901 | $6 | $22 |
| Iron infusion (Monoferric) | 2,900 | $16 | $57 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,250 | $1 | $28 |
| Injection, bortezomib, 0.1 mg | 2,049 | $4 | $113 |
| Injection, docetaxel, 1 mg | 1,857 | $1 | $7 |
| Office visit, established patient (20-29 min) | 1,680 | $69 | $239 |
| Contrast dye for imaging (iodine-based) | 1,640 | $0 | $1 |
| Anti-nausea injection (ondansetron/Zofran) | 1,120 | $0 | $9 |
| Injection, atropine sulfate, 0.01 mg | 1,000 | $0 | $1 |
| Injection, leucovorin calcium, per 50 mg | 978 | $3 | $12 |
| Drug injection, under skin or into muscle | 937 | $11 | $69 |
| Injection, fulvestrant, 25 mg | 760 | $9 | $132 |
| Administration of chemotherapy into vein, 1 hour or less | 720 | $104 | $378 |
| Injection of additional new drug or substance into vein | 702 | $12 | $61 |
| Automated urinalysis | 636 | $2 | $8 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 618 | $3 | $205 |
| Injection, fluorouracil, 500 mg | 548 | $2 | $7 |
| Injection, carboplatin, 50 mg | 406 | $2 | $41 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 402 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 331 | $23 | $84 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 313 | $50 | $189 |
| Cyclophosphamide, 100 mg | 313 | $16 | $79 |
| Complete ultrasound scan behind abdominal cavity | 310 | $82 | $297 |
| Injection, diphenhydramine hcl, up to 50 mg | 308 | $1 | $3 |
| Red blood count, automated test | 302 | $4 | $10 |
| Administration of chemotherapy into vein, each additional hour | 288 | $23 | $79 |
| Administration of additional new drug or substance into vein, 1 hour or less | 239 | $52 | $178 |
| Office visit, established patient (30-39 min) | 226 | $100 | $339 |
| Injection, zoledronic acid, 1 mg | 206 | $6 | $69 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 187 | $135 | $562 |
| Injection, doxorubicin hydrochloride, 10 mg | 184 | $2 | $13 |
| Injection, cisplatin, powder or solution, 10 mg | 170 | $2 | $13 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 161 | $56 | $206 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 152 | $25 | $89 |
| Infusion, normal saline solution , 1000 cc | 142 | $2 | $7 |
| Bladder ultrasound after voiding | 134 | $8 | $51 |
| Injection of drug or substance into vein | 131 | $30 | $156 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 129 | $16 | $56 |
| Ultrasound scan of pelvic region through rectum | 128 | $103 | $344 |
| Electronic assessment of bladder emptying | 120 | $8 | $135 |
| Infusion into a vein for hydration, 31-60 minutes | 101 | $25 | $156 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 89 | $18 | $59 |
| New patient office visit (45-59 min) | 86 | $121 | $453 |
| Injection, magnesium sulfate, per 500 mg | 86 | $1 | $2 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 77 | $1 | $7 |
| Limited ultrasound scan of pelvis | 72 | $28 | $128 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 63 | $133 | $637 |
| Hospital follow-up visit, high complexity | 60 | $97 | $285 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 59 | $27 | $517 |
| Administration of additional new drug or substance into vein using push technique | 58 | $45 | $170 |
| Insertion of device into abdomen with pressure and urine flow rate study | 57 | $152 | $295 |
| Infusion into a vein for hydration, each additional hour | 51 | $10 | $42 |
| Drawing of blood for a medical problem | 44 | $77 | $277 |
| Insertion of lower leg neurostimulator electrode | 40 | $93 | $335 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 35 | $16 | $56 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 34 | $299 | $894 |
| New patient office visit (30-44 min) | 33 | $77 | $298 |
| Office visit, established patient (10-19 min) | 31 | $41 | $147 |
| Hospital follow-up visit, moderate complexity | 31 | $64 | $197 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 26 | $3 | $11 |
| Injection, lorazepam, 2 mg | 24 | $1 | $2 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 23 | $294 | $827 |
| Initial hospital admission, high complexity | 20 | $140 | $556 |
| Ct scan of abdomen and pelvis before and after contrast | 19 | $199 | $708 |
| New patient office visit, complex (60-74 min) | 17 | $168 | $585 |
| Office visit, established patient, complex (40-54 min) | 15 | $145 | $474 |
| Initial hospital admission, moderate complexity | 15 | $105 | $377 |
| Ultrasound scan of scrotum | 13 | $61 | $177 |
| 3d radiographic procedure with computerized image postprocessing | 11 | $31 | $82 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
33.9% high complexity
61.6% medium
4.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$20,223
Total received (2018-2024)
Avg $2,889/year across 7 years
Top 23% in FL for hematology
84
Companies
1,146
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,120 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$104 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,599
2023$2,915
2022$3,638
2021$3,227
2020$2,587
2019$2,749
2018$3,509
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$1,505
Novartis Pharmaceuticals Corporation
$1,490
AstraZeneca Pharmaceuticals LP
$1,348
PFIZER INC.
$1,259
Janssen Biotech, Inc.
$1,197
Celgene Corporation
$1,187
Amgen Inc.
$1,163
GlaxoSmithKline, LLC.
$730
Merck Sharp & Dohme Corporation
$677
Seagen Inc.
$594
GENZYME CORPORATION
$535
Daiichi Sankyo Inc.
$529
Bayer HealthCare Pharmaceuticals Inc.
$523
Incyte Corporation
$483
Pharmacyclics LLC, An AbbVie Company
$441
Lilly USA, LLC
$414
Ipsen Biopharmaceuticals, Inc
$338
Merck Sharp & Dohme LLC
$332
TESARO, Inc.
$326
Takeda Pharmaceuticals U.S.A., Inc.
$306
Gilead Sciences, Inc.
$275
ARRAY BIOPHARMA INC
$239
JAZZ PHARMACEUTICALS INC.
$232
Genentech USA, Inc.
$217
Taiho Oncology, Inc.
$210
Astellas Pharma US Inc
$198
Boehringer Ingelheim Pharmaceuticals, Inc.
$193
EISAI INC.
$184
BeiGene USA, Inc.
$168
AMAG Pharmaceuticals, Inc.
$161
Regeneron Healthcare Solutions, Inc.
$159
ABBVIE INC.
$139
Clovis Oncology, Inc.
$137
Eisai Inc.
$131
AbbVie Inc.
$126
Puma Biotechnology, Inc.
$118
Alexion Pharmaceuticals, Inc.
$114
Boston Scientific Corporation
$109
PUMA BIOTECHNOLOGY, INC.
$103
AVEO Pharmaceuticals, Inc.
$92
Dova Pharmaceuticals
$89
Bayer Healthcare Pharmaceuticals Inc.
$86
Aveo Pharmaceuticals, Inc.
$81
Pharmacyclics LLC, an AbbVie Company
$77
Myovant Sciences Inc.
$70
TerSera Therapeutics LLC
$66
Karyopharm Therapeutics Inc.
$66
EUSA Pharma (US) LLC
$58
Myriad Genetic Laboratories, Inc.
$53
Fennec Pharmaceuticals, Inc.
$49
AbbVie, Inc.
$48
Rigel Pharmaceuticals, Inc.
$47
Biocon Biologics Inc
$46
Dendreon Pharmaceuticals LLC
$45
EMD Serono, Inc.
$44
Kite Pharma, Inc.
$41
MorphoSys, US Inc.
$39
Agios Pharmaceuticals, Inc.
$36
Helsinn Therapeutics (U.S.), Inc.
$35
Exelixis Inc.
$34
Janssen Pharmaceuticals, Inc
$34
Blueprint Medicines Corporation
$26
Seattle Genetics, Inc.
$26
Adaptive Biotechnologies Corporation
$26
Azurity Pharmaceuticals, Inc.
$23
G1 Therapeutics, Inc.
$22
Foundation Medicine, Inc.
$20
Kyowa Kirin, Inc.
$19
Advanced Accelerator Applications
$19
Alnylam Pharmaceuticals Inc.
$18
Shire North American Group Inc
$17
Octapharma USA, Inc.
$17
CSL Behring
$17
Sirtex Medical Inc
$17
Array BioPharma Inc.
$16
Partner Therapeutics, Inc.
$16
Sun Pharmaceutical Industries Inc.
$15
SUN PHARMACEUTICAL INDUSTRIES INC.
$14
Deciphera Pharmaceuticals Inc.
$14
Jazz Pharmaceuticals Inc.
$14
Sobi, Inc
$13
Sysmex Inostics Inc
$12
Secura Bio, Inc.
$12
Veracyte, Inc.
$2
Top 3 companies account for 21.5% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AMS · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Enhertu · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Fulphila · GAMMAGARD · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INTRAROSA · Imbruvica · JAKAFI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LEUKINE · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONPATTRO · OPDIVO · OPDUALAG · ORGOVYX · Ogivri · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pedmark · Phesgo · Pomalyst · Prolia · QINLOCK · QUZYTTIR · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Trodelvy · VARUBI · VENCLEXTA · VERZENIO · VIVIMUSTA · VOTRIENT · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · YONSA · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $8 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
4
Per 100K population
2.4
County median income
$71,049
Nearest hospital
CLEVELAND CLINIC INDIAN RIVER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Byer is a mixed practice specialist, with above-average Medicare volume (top 13% in FL), and low-engagement industry engagement, with 15 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Byer experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Byer performed 75,480 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Byer receive payments from pharmaceutical companies?
Yes. Dr. Byer received a total of $20,223 from 84 companies across 1,146 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Byer's costs compare to other hematologys in Vero Beach?
Dr. Byer's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Byer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Vero Beach
Browse hematologys in Vero Beach ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology